Intermediate-Dose Enoxaparin After Cardiac Ablation Procedures

Journal Title: Journal of Hypertension and Cardiology - Year 2014, Vol 1, Issue 3

Abstract

Objective: Ablation of foci within the atria has been shown to resolve symptoms of atrial fibrillation and atrial flutter. However, no standard has been established for anticoagulation after the procedure. Enoxaparin has been well described in the literature as a means to provide anticoagulation after ablation procedures. The only enoxaparin doses previously studied were 0.5 mg/kg and 1 mg/kg, both given every 12 hours. The purpose of the study was to compare the incidence of a major bleed or vascular complication in patients who received enoxaparin doses between 0.5 mg/kg and 1 mg/kg every 12 hours with patients who received either 0.5 mg/kg or 1 mg/kg every 12 hours. Methods: This IRB-approved, single-center, retrospective, cohort study included subjects greater than 18 years of age who received an atrial fibrillation or atrial flutter ablation procedure and at least one dose of enoxaparin post-ablation. Results: There were 119 subjects who satisfied the inclusion criteria. The primary outcome, incidence of major bleeding or vascular complication, did not demonstrate a statistically significant difference between groups (p = 0.92). The incidences were 4.8% with enoxaparin ≥ 1 mg/kg, 3% with enoxaparin between 0.5 mg/kg and 1 mg/kg, and 3.2% with enoxaparin ≤ 0.5 mg/kg. No subject experienced an ischemic stroke or transient ischemic attack within 28 days of a cardiac ablation procedure. Conclusion: Significant increases in major bleeding or vascular complications may not exist with an intermediate dose of enoxaparin provided after a cardiac ablation procedure.

Authors and Affiliations

Drayton A. Hammond, Christina E. DeRemer, David M. Killough, Adam E. Berman

Keywords

Related Articles

Vascular Damage in Newly Diagnosed Young Hypertensive Patients, Assessed by Carotid Intima Media Thickness: An Indian Perspective

Background: Western studies have shown that hypertension increases carotid intima media thickness (cIMT) as early as in childhood and adolescence. However, similar data from India is lacking. Indians have different genet...

Late Age at Menarche Increased Common Carotid Artery Intima-Media Thickness in Overweight and Obese Women

Objective: To determine whether age at menarche is an independent predictor of common carotid artery intima-media thickness in overweight and obese adult women. Methods: 403 overweight and obese women, aged 18–72 year...

A Potential New Technique to Estimate the Origins of Focal Atrial Tachycardias from 12-Lead Electrocardiograms

Background: This brief report presents a potential new technique for locating the sites of origin of focal atrial tachycardias from standard 12-lead electrocardiograms. Methods: Estimated P wave vector coordinates are...

Sotos Syndrome, Isolated Left Ventricular Non Compaction Cardiomyopathy and Ventricular Pre Excitation: A Case Report.

We report the case of a 22 year-old-male patient affected by Sotos syndrome was preoperatively and urgently evaluated for tracheal stent implantation due to respiratory insufficiency caused by idiopathic tracheal stenosi...

Download PDF file
  • EP ID EP279572
  • DOI 10.14302/issn.2329-9487.jhc-13-313
  • Views 139
  • Downloads 0

How To Cite

Drayton A. Hammond, Christina E. DeRemer, David M. Killough, Adam E. Berman (2014). Intermediate-Dose Enoxaparin After Cardiac Ablation Procedures. Journal of Hypertension and Cardiology, 1(3), 22-29. https://europub.co.uk/articles/-A-279572